Eliquent delivers regulatory consulting services to life sciences companies, providing solutions throughout the product life cycle for regulatory challenges, market authorization, and compliance.

Eliquent

ELIQUENT Life Sciences | 2,528 followers on LinkedIn. Regulatory Clarity - thought to finish. | We are expert consultants delivering the answers and solutions that life sciences innovators need to gain and maintain market authorization for their products.

Our unprecedented assembly of regulatory leaders, industry experts, and technical specialists collaborate seamlessly to unlock excellence throughout the product lifecycle. We are the convergence of regulatory expertise and technical capabilities across the therapeutic landscape.

Executive Transition Coach, Leadership & Governance, Life Sciences

Martin Hedley

Vice President, Nonclinical Team Lead, ELIQUENT Life Science

Julia Carrier, PhD.

Experienced Consultant in Pharmaceutical and Medical Device Industries |Trainer | Based in Greenville |Open to Traveling

David Husman

CEO, Non-Executive Director and Consultant

Alistair Macdonald

ELIQUENT Life Sciences

ELIQUENT Life Sciences ’ fully integrated PV and risk management solutions support clients at every stage, ensuring patient safety and streamlined compliance. Learn more by downloading our new PV Information Sheet or visiting https://lnkd.in/eVMuCdRD

Elevate your risk management capabilities with ELIQUENT Life Sciences ' expanded pharmacovigilance (PV) and risk management solutions. Guided by internationally recognized PV expert – Shelley Gandhi – ELIQUENT’s global PV solutions work in concert with our fully integrated platform to provide clients with seamless support from the earliest phases of development through post-market monitoring. Learn more about ELIQUENT’s integrated PV solutions by downloading our new Information Sheet or visiting eliquent.com

ELIQUENT Life Sciences is excited to attend this year's #BioEurope . Stop by booth #106 to meet our team of experts - Shelley Gandhi , Rob Wojciechowski , Ifty Saiyed , and Masayoshi Takezawa - and learn how ELIQUENT brings clarity to regulatory complexity with a full-service approach and comprehensive solutions that bridge the spectrum of regulatory challenges. ELIQUENT.com

Exciting news - Shelley Gandhi - internationally recognized pharmacovigilance expert - has joined the ELIQUENT Life Sciences team. Bolstered by this incredible talent, ELIQUENT's integrated platform of full-service solutions now includes an expanded portfolio of Pharmacovigilance and Risk Management Solutions. Connect with Shelley this week at #BIOEurope - ELIQUENT booth #106 - and learn more about our comprehensive #pharmacovigilance capabilities at https://lnkd.in/eVMuCdRD

I’m thrilled to announce that I’ve recently joined the executive leadership team at Eliquent Life Sciences! It’s both an honour and privilege to work with a talented team in a world-leading consultancy that specializes in quality, regulatory and safety. I’m excited by the opportunity to lead Eliquent’s growth on a global scale, guiding our next chapter of innovation and impact in life science industry. Here’s to the exciting journey ahead!

Rob Wojciechowski

ELIQUENT Life Sciences is thrilled to announce that Robert Wojciechowski has joined our leadership team. A seasoned life sciences executive, Rob brings more than 20 years of leadership experience to his role at ELIQUENT. Connect with Rob next week at #BIOEurope - he an members of ELIQUENT's on-site team will be at booth #106.

#BIOEurope is less than two weeks away. Stop by booth #106 to meet the ELIQUENT Life Sciences team of experts and learn how ELIQUENT brings clarity to regulatory complexity with a full-service approach and comprehensive solutions that bridge the spectrum of regulatory challenges. Learn more at ELIQUENT.com

ELIQUENT Life Sciences expert, Elizabeth Oestreich , will moderate a Food and Drug Law Institute (FDLI) panel addressing Non-Combustible Nicotine Product Standards at Thursday's FDLI Tobacco & Nicotine Products Regulation and Policy Conference.

Experience the power of clarity. ELIQUENT’s Regulatory Writing Solutions unlock the full potential of your product’s journey by creating a compelling narrative that resonates with regulators and positions your product for success. Whether you're submitting to the #FDA , #EMA , or other global regulatory bodies, our highly specialized medical writing team supports your regulatory objectives and strengthens your marketing position. Learn more at https://lnkd.in/ewwXquVE

ELIQUENT Life Sciences expert Kalah Auchincloss is a featured speaker at today’s Food and Drug Law Institute (FDLI) Advertising & Promotion for Medical Products Conference. Kalah and her co-panelist will address Off-Label Promotion in a Post-Chevron Environment. Register for today's conference at https://lnkd.in/e_pEPprR and learn more about ELIQUENT's comprehensive capabilities at ELIQUENT.com

Metric
Company Name	Eliquent
Symbol
MSH ID	COM:ELIQUENT
Market	PRIVATE
Sector	Commercial & Professional Services
Industry	Regulatory Consulting
Country	US
Stage
Employee Count
Website	eliquent.com
LinkedIn	eliquent-life-sciences
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	372
Web Traffic Growth	-0.76
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

ELIQ

COM:ELIQUENT

Eliquent

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue